Edition:
United Kingdom

Cancer Genetics Inc (CGIX.OQ)

CGIX.OQ on NASDAQ Stock Exchange Capital Market

1.22USD
25 Sep 2018
Change (% chg)

$-0.02 (-1.61%)
Prev Close
$1.24
Open
$1.22
Day's High
$1.22
Day's Low
$1.22
Volume
819
Avg. Vol
18,733
52-wk High
$3.45
52-wk Low
$0.83

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -0.17 December 26 Sep 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 1 1
(2) OUTPERFORM 1 1 1 1
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.67 2.67 2.25 2.25

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 2 7.57 8.09 7.05 11.73
Quarter Ending Dec-18 2 8.12 9.20 7.05 12.61
Year Ending Dec-18 2 30.40 31.99 28.80 43.45
Year Ending Dec-19 2 50.16 53.51 46.82 50.09
Earnings (per share)
Quarter Ending Sep-18 2 -0.17 -0.16 -0.18 -0.04
Quarter Ending Dec-18 2 -0.16 -0.12 -0.19 -0.01
Year Ending Dec-18 2 -0.62 -0.58 -0.67 -0.17
Year Ending Dec-19 2 -0.22 -0.11 -0.34 -0.20

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 8.30 7.04 1.27 15.25
Quarter Ending Mar-18 8.20 7.67 0.53 6.49
Quarter Ending Dec-17 9.19 7.52 1.67 18.16
Quarter Ending Sep-17 7.91 8.03 0.11 1.45
Quarter Ending Jun-17 7.97 6.60 1.36 17.10

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 7.57 7.57 7.57 8.81 11.73
Quarter Ending Dec-18 8.12 8.12 8.12 9.44 12.61
Year Ending Dec-18 30.40 30.40 30.40 34.22 43.45
Year Ending Dec-19 50.16 50.16 50.16 49.19 50.09

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings